Abbott’s paravalvular leak treatment secures FDA approval
Abbott’s Amplatzer Paraclose Occluder has secured US Food and Drug Administration (FDA) approval, making it the first transcatheter device approved…
All articles by Ross Law
Ross Law
Ross Henry Law is a reporter for Medical Device Network. His key interest areas in healthcare include regulation, mental health, neurology, oncology, and Alzheimer's disease. Ross also has extensive prior experience in covering the captive insurance, retail, and technology sectors.
-
-
Baxter’s shares fall as Q3 probability dips despite revenue growth
Baxter has reported Q3 revenues of almost $3bn, but as it raises its 2026 outlook for the second consecutive quarter…
-
BMA laments low NHS investment in UK’s Autumn Budget
Doctors have expressed disappointment at the lack of focus on the healthcare sector in the Autumn Budget, particularly given that…
-
Podcast: Boston Scientific on the growing importance of clinical evidence in cardiology
Cardiovascular diseases (CVD) such as stroke and heart attack remain the leading cause of mortality globally, as per the World…
-
GE HealthCare raises 2026 outlook after positive Q3
GE HealthCare has reported revenues of $5.5bn in Q3, with notable year-over-year (YoY) growth in its pharmaceutical diagnostics (PDx) segment,…
-
Pharaoh’s CSF management system secures FDA breakthrough designation
The US Food and Drug Administration (FDA) has granted breakthrough device designation to Pharaoh Neuro’s Neurapheresis, setting a course for…
-
Bracco Imaging outlays $230m to establish contrast media site in North Carolina
Bracco Imaging is investing $230m to establish its first site on US soil to advance supply chain resilience and meet…
-
Podcast: Insights from AdvaMed 2026
The curtain has closed on this year's edition of the Advanced Medical Technology Association's MedTech Conference. Commonly referred to as…
-
ESMO26: Wider use of breast cancer gene test could save NHS £4m annually
A genomic test to support treatment decision-making for women with early breast cancer could save the UK National Health Service…
-
RadNet acquires ONRAD in $355m deal to broaden radiology provision
RadNet has agreed to acquire ONRAD in a $355m deal positioned to advance its technology and service offering, as well…